rs374574870
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_001083961.2(WDR62):c.4527G>A(p.Ser1509Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000698 in 1,603,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000070 ( 0 hom. )
Consequence
WDR62
NM_001083961.2 synonymous
NM_001083961.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.13
Publications
1 publications found
Genes affected
WDR62 (HGNC:24502): (WD repeat domain 62) This gene is proposed to play a role in cerebral cortical development. Mutations in this gene have been associated with microencephaly, cortical malformations, and cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]
WDR62 Gene-Disease associations (from GenCC):
- microcephaly 2, primary, autosomal recessive, with or without cortical malformationsInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P, ClinGen
- autosomal recessive primary microcephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 19-36104983-G-A is Benign according to our data. Variant chr19-36104983-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 437287.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.13 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152220Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
11
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000125 AC: 29AN: 231810 AF XY: 0.000149 show subpopulations
GnomAD2 exomes
AF:
AC:
29
AN:
231810
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000696 AC: 101AN: 1451476Hom.: 0 Cov.: 34 AF XY: 0.0000721 AC XY: 52AN XY: 721628 show subpopulations
GnomAD4 exome
AF:
AC:
101
AN:
1451476
Hom.:
Cov.:
34
AF XY:
AC XY:
52
AN XY:
721628
show subpopulations
African (AFR)
AF:
AC:
8
AN:
33368
American (AMR)
AF:
AC:
7
AN:
44196
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25974
East Asian (EAS)
AF:
AC:
2
AN:
39484
South Asian (SAS)
AF:
AC:
21
AN:
85328
European-Finnish (FIN)
AF:
AC:
0
AN:
49322
Middle Eastern (MID)
AF:
AC:
0
AN:
4190
European-Non Finnish (NFE)
AF:
AC:
53
AN:
1109656
Other (OTH)
AF:
AC:
10
AN:
59958
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74496 show subpopulations
GnomAD4 genome
AF:
AC:
11
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74496
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41574
American (AMR)
AF:
AC:
2
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
AC:
1
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5
AN:
68034
Other (OTH)
AF:
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Jun 22, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Nov 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.